glp1.how

advocacy

Advocating for coverage when you don't have a qualifying diagnosis code yet

Coverage criteria are often built around a specific BMI threshold or diagnosis code — but real health risk doesn't always map cleanly onto those numbers. Here's how to build a case when you don't yet technically qualify.

Updated Jul 14, 2026

Why this gap exists

Insurance coverage criteria for GLP-1 medications typically hinge on specific, bright-line thresholds — a BMI cutoff, a documented comorbidity, or a formal diabetes or prediabetes diagnosis. But clinical risk doesn't always map neatly onto these thresholds: someone just under a BMI cutoff, or with metabolic risk factors that haven't yet been formally diagnosed as a named comorbidity, can have genuine medical need that coverage criteria don't capture.

What to do if you're close but don't technically qualify

  1. Ask your prescriber about a comprehensive workup, not just a BMI check. Metabolic markers like insulin resistance, blood pressure, cholesterol panels, or a sleep study for suspected sleep apnea can sometimes surface a qualifying comorbidity you weren't previously diagnosed with.
  2. Understand that "not medically necessary" is a specific coding determination, not a final clinical judgment. A denial based on not meeting formulary criteria is different from a determination that treatment wouldn't help you — worth keeping in mind emotionally as much as procedurally.
  3. Ask your prescriber to document risk factors thoroughly, even ones that don't map to a single diagnosis code — family history, trending lab values, or functional limitations can sometimes support a medical necessity argument in an appeal even without a clean qualifying diagnosis.
  4. Explore whether your plan has an exception process separate from standard prior authorization — many plans allow a formulary exception request when standard criteria don't fit a patient's specific clinical picture.

If coverage still isn't available

  • Ask about manufacturer savings programs (see LillyDirect and NovoCare), some of which have their own eligibility criteria separate from insurance coverage.
  • Revisit the conversation periodically. Formulary criteria and clinical guidelines shift over time — a denial today doesn't necessarily reflect what's possible in six or twelve months, especially as coverage criteria continue to evolve alongside growing clinical evidence.
  • Consider whether your case is a good candidate for broader advocacy, not just your individual appeal — patterns of people falling just outside coverage thresholds are exactly the kind of data patient advocacy organizations use to push for criteria changes (see the role of patient advocacy organizations).

The bottom line

Coverage thresholds are administrative lines, not always perfect reflections of clinical need. If you fall just outside one, a thorough workup, careful documentation, and persistence — both in your individual case and potentially in broader advocacy — are reasonable paths forward.